Overview

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

Summary

Study to provide initial data to assess the safety and efficacy of tegaserod use in patients with dyspepsia that are being treated with proton pump inhibitors (PPI's) for heartburn.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Proton Pump Inhibitors
Tegaserod